Skip to content

Clinical trials

Completed Phase 4 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Status: Completed Clear all

331 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
200115
20026
200330
200426
200532
200632
200722
200828
200917
201016
201113
201213
201310
20149
20158
20164
20178
20189
20195
20201
20212
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed331

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company16
Massachusetts General Hospital14
AstraZeneca9
University of California, Los Angeles9
University of Maryland, Baltimore9
Janssen Korea, Ltd., Korea8
North Suffolk Mental Health Association7
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.7
Nathan Kline Institute for Psychiatric Research6
National Institute of Mental Health (NIMH)6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia331
Psychotic Disorders137
Bipolar Disorder21
Metabolic Syndrome12
Diabetes Mellitus10
Insulin Resistance8
Alcoholism7
Mental Disorders7
Substance-Related Disorders7
Obesity6

Trials

Showing 1 to 25 of 331. Each trial links to its page on Pharma Observatory.

231 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.